➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Mallinckrodt
Baxter
Express Scripts
Dow

Last Updated: August 2, 2021

DrugPatentWatch Database Preview

CEFZIL Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Cefzil patents expire, and when can generic versions of Cefzil launch?

Cefzil is a drug marketed by Corden Pharma and is included in two NDAs.

The generic ingredient in CEFZIL is cefprozil. There are thirteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cefprozil profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cefzil

A generic version of CEFZIL was approved as cefprozil by CHARTWELL RX on November 14th, 2005.

  Free Forever Trial

Drug patent expirations by year for CEFZIL
Recent Clinical Trials for CEFZIL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ranbaxy Laboratories LimitedN/A
Teva Pharmaceuticals USAPhase 1
SandozPhase 1

See all CEFZIL clinical trials

US Patents and Regulatory Information for CEFZIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Corden Pharma CEFZIL cefprozil FOR SUSPENSION;ORAL 050665-001 Dec 23, 1991 DISCN Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Corden Pharma CEFZIL cefprozil TABLET;ORAL 050664-002 Dec 23, 1991 DISCN Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Corden Pharma CEFZIL cefprozil FOR SUSPENSION;ORAL 050665-002 Dec 23, 1991 DISCN Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Mallinckrodt
Baxter
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.